On the Record · Royalty Pharma
Royalty Pharma subsidiaries, as it lists them
The subsidiaries Royalty Pharma lists in its latest annual report, with the jurisdiction of each, linked to the filing.
Subsidiaries it lists
| Subsidiary | Jurisdiction |
|---|---|
| Royalty Pharma Holdings Ltd | England and Wales |
| Royalty Pharma Investments 2019 ICAV | Ireland |
| RPI 2019 Intermediate Finance Trust | Delaware |
| Royalty Pharma Investments 2011 ICAV | Ireland |
| RPI Finance Trust | Delaware |
| Royalty Pharma Investments 2023 ICAV | Ireland |
| Royalty Pharma Development Funding, LLC | Delaware |
| Royalty Pharma Manager, LLC | Delaware |
From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.
Read from Royalty Pharma’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-11. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.